Clinical Trial Update: Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating sildenafil for newborns with persistent pulmonary hypertension was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Persistent Pulmonary Hypertension of the Newborn
• Respiratory Failure

Drugs mentioned

• SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Persistent Pulmonary Hypertension, Respiratory Failure | Phase 2 | Status: TERMINATED | Results posted: 2019-02-01